SARS-CoV-2 Nucleocapsid 抗体
(1 reference)Quick Overview for SARS-CoV-2 Nucleocapsid 抗体 (ABIN6952788)
抗原
See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
纯化方法
- Protein A purified
-
纯度
- ≥95 % as determined by SDS-PAGE
-
免疫原
- 2019 nCOV N protein
-
亚型
- IgG1
-
-
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (Whole Molecule) antibody
Animal-Free SARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, WB, IF, FACS 宿主: 小鼠 Monoclonal AB79-E11 unconjugated Recombinant Antibody
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (AA 1-419) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, WB, GICA 宿主: HEK-293 Cells Chimeric 1A6 unconjugated scFv fragment Recombinant Antibody
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) ELISA, IF 宿主: 兔 Chimeric CR3018 (03-018) unconjugated Recombinant Antibody
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, WB, IF 宿主: 小鼠 Monoclonal unconjugated
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (AA 1-419) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA, GICA 宿主: Human Chimeric 1A6 unconjugated scFv fragment Recombinant Antibody
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (AA 1-419) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2), Virus ELISA, WB 宿主: 兔 Polyclonal unconjugated
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (AA 1-419) antibody (HRP)SARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) ELISA 宿主: Human Monoclonal 1A6 HRP scFv fragment Recombinant Antibody
anti-SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) (C-Term) antibodySARS-CoV-2 N 适用: SARS Coronavirus-2 (SARS-CoV-2) WB 宿主: 山羊 Polyclonal unconjugated
-
-
应用备注
- ELISA: Use at an assay dependent concentration(Suggestions: Use a concentration of 0.1 - 1 μg/mL)
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- CB buffer,
-
注意事项
- Avoid repeated freeze / thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
有效期
- 12 months
-
-
-
: "Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial." in: Virus research, Vol. 316, pp. 198791, (2022) (PubMed).
-
: "Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial." in: Virus research, Vol. 316, pp. 198791, (2022) (PubMed).
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
别名
- SARS-CoV-2 Nucleocapsid protein
-
物质类
- Viral Protein
-
背景
- Synonyms: Background:
-
分子量
- 48 kDa
抗原
-
